Delivery Order SPE2DB22D3019-SPE2DB25FK4ER
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,962.21 to AmerisourceBergen Drug Corp for Repatha 140 mg/mL SureClick auto-injectors, with an ultimate completion date of July 22, 2025. This competitively awarded, firm fixed-price delivery order was issued under a non-set-aside procurement and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. Repatha is a prescription medication used to lower cholesterol levels, and this delivery...
- The Defense Logistics Agency awarded a delivery order valued at $2,603.55 to AmerisourceBergen Drug Corp for Repatha 140 mg/mL SureClick auto-injectors, with an ultimate completion date of August 4, 2025. This non-competitive delivery order represents a firm fixed-price transaction executed on August 1, 2025, with the product to be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Repatha is a prescription medication used to lower cholesterol levels and...
- The Defense Logistics Agency awarded a delivery order valued at $1,041.42 to AmerisourceBergen Drug Corp for Repatha 140 mg/ml SureClick auto-injectors, with a completion date of July 23, 2025. This non-competitive, firm fixed-price delivery order was issued on July 22, 2025, and will be performed at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. Repatha is a prescription medication used to treat high cholesterol and reduce the risk of cardiovascular disease. This...
- The Defense Logistics Agency awarded a delivery order valued at $2,270.22 to AmerisourceBergen Drug Corp for Repatha 140 mg/ml SureClick auto-injectors, with an ultimate completion date of August 22, 2025. This firm fixed-price delivery order, issued on August 21, 2025, represents a non-set-aside competitive award and will be performed at the contractor's facility in Conshohocken, Pennsylvania. Repatha is a prescription medication used to lower cholesterol levels in patients with certain...
- The Defense Logistics Agency awarded a $4,456.60 delivery order to AmerisourceBergen Drug Corp on August 7, 2025, for the supply of Repatha 140 mg/mL SureClick auto-injectors. This firm fixed-price delivery order, which is not set-aside, is scheduled for completion by August 8, 2025, and will be performed at the contractor's location in Conshohocken, Pennsylvania. Repatha is a prescription medication used to treat high cholesterol in patients who require additional lipid management beyond...
- The Defense Logistics Agency awarded a delivery order valued at $1,127.20 to AmerisourceBergen Drug Corp for Repatha 140 mg/mL SureClick auto-injector pharmaceutical products. This firm fixed price, non-set-aside delivery order was executed on August 5, 2025, with an ultimate completion date of August 6, 2025. The product will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Repatha is a prescription medication used to treat high cholesterol and reduce...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $2,270.22 for Repatha 140 mg/mL SureClick on August 29, 2025, with completion expected by September 2, 2025. This firm fixed price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. Repatha is a prescription medication used to lower cholesterol levels and reduce cardiovascular risk in eligible patients....
- The Defense Logistics Agency awarded a delivery order valued at $1,041.42 to AmerisourceBergen Drug Corp for Repatha 140 mg/ml SureClick auto-injectors, with an ultimate completion date of July 21, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's broader pharmaceutical supply...
- The Defense Logistics Agency awarded a $27,040.46 delivery order to AmerisourceBergen Drug Corp for Repatha 140 mg/mL SureClick auto-injectors, with a completion date of September 3, 2025. This competitively awarded, firm fixed-price contract contains no set-aside designation and is being performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support...
- The Defense Logistics Agency awarded a delivery order valued at $4,151.17 to AmerisourceBergen Drug Corp for Repatha 140 mg/mL SureClick auto-injector medication, with an ultimate completion date of August 22, 2025. This is a firm fixed price delivery order executed on August 21, 2025, with no set-aside designation, meaning it was competitively awarded. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- SPE2DB22D3019Indefinite Delivery Contract
- SPE2DB22D3019-SPE2DB25FK4ERDelivery Order
The Defense Logistics Agency awarded a $34,401.14 delivery order to AmerisourceBergen Drug Corp for Repatha 140 mg/ml SureClick auto-injector medication, with an ultimate completion date of September 9, 2025. This is a competitively awarded, firm fixed-price delivery order with no set-aside designation. The award was issued on September 8, 2025, with performance to be executed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Repatha is a prescription medication used to lower cholesterol levels in patients with certain cardiovascular conditions. This delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The prime IDV serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply a broad range of medications and medical supplies to support military healthcare programs worldwide. As a major pharmaceutical distributor, AmerisourceBergen has demonstrated capability to fulfill federal medical procurement requirements through open competition, serving customers including the Defense Health Agency and U.S. Coast Guard across multiple therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $34.4k | 9/8/25 |